Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients

Table 7

Logistic regression analysis with nongenetic and genetic factors in total population.

Variables	𝐵	𝑃 value	Exp (𝐵)	95% C.I.
P2Y12 CpG1	−0.141	0.096	0.869	0.74–1.03
P2Y12 CpG2	0.169	0.142	1.184	0.95–1.49
Age	0.047	0.163	1.048	0.98–1.12
Gender (male)	−0.591	0.399	0.554	0.14–2.19
Hypertension	0.569	0.324	1.767	0.57–5.47
DM	−0.979	0.282	0.376	0.06–2.24
Dyslipidemia	−0.538	0.395	0.584	0.17–2.02
Current smoking	−0.378	0.573	0.685	0.18–2.55
Alcohol abuse	1.010	0.214	2.746	0.56–13.51
BMI	−0.073	0.514	0.930	0.75–1.16
Stent	0.865	0.009	2.374	1.24–4.53
LEVF	−0.035	0.368	0.965	0.89–1.04
TC	0.093	0.847	1.097	0.43–2.82
Triglycerides	0.081	0.770	1.084	0.63–1.86
HDL	−1.283	0.308	0.277	0.02–3.27
LDL	−0.408	0.481	0.665	0.21–2.07
GLU	0.681	0.013	1.976	1.15–3.39
HbAC1	−0.907	0.022	0.404	0.19–0.88
ALT	−0.009	0.541	0.992	0.97–1.02
AST	0.002	0.366	1.002	1.00–1.01
TBIL	−0.036	0.357	0.965	0.89–1.04
A	−0.091	0.264	0.913	0.78–1.07
BUN	−0.161	0.292	0.851	0.63–1.15
CR	−0.004	0.825	0.996	0.97–1.03
UA	0.002	0.455	1.002	1.00–1.01
CRP	−0.007	0.677	0.993	0.96–1.03
PLT	0.008	0.712	1.008	0.97–1.05
MPV	0.380	0.507	1.462	0.48–4.50
PCT	−13.635	0.639	0.000	0.00–6.71𝐸+18
PDW	−0.183	0.736	0.832	0.29–2.42
Constant	8.480	0.469	4815.697